We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Series of preclinical studies demonstrate the therapeutic potential of PAT-DX1, a first-in-class, synthetically lethal DNA-binding antibody in primary brain cancers and brain metastases. Patrys...
PAT-SM6 clinical trial data from all 4 cohorts to be presented at prestigious American Society of Hematology conference From 11 currently evaluable patients, 4 (36%) experienced stable...
Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1 - Laureate Biopharmaceutical Services to manufacture lead product PAT-LM1 Appointment follows Laureate exceeding yield...
NEW YORK, May 24 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today began trading Citigroup Funding Inc.'s PACERS Linked to eBay Inc. Priced at $10.00 per unit with an initial offer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.004 | 0.005 | 0.004 | 1138482 | 0.00411066 | DE |
4 | 0 | 0 | 0.004 | 0.005 | 0.003 | 2507264 | 0.00385886 | DE |
12 | -0.0025 | -38.4615384615 | 0.0065 | 0.0075 | 0.003 | 2914508 | 0.00377026 | DE |
26 | -0.003 | -42.8571428571 | 0.007 | 0.008 | 0.003 | 1747214 | 0.00481185 | DE |
52 | -0.004 | -50 | 0.008 | 0.01 | 0.003 | 1345763 | 0.00628686 | DE |
156 | -0.034 | -89.4736842105 | 0.038 | 0.045 | 0.003 | 2381955 | 0.02081112 | DE |
260 | -0.017 | -80.9523809524 | 0.021 | 0.063 | 0.003 | 4361798 | 0.02945054 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions